0

Dacarbazine Related Compound A

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP72402
CAS72-40-2
Structure
MDL NumberMFCD00012704
Molecular Weight162.58
InChI KeyMXCUYSMIELHIQL-UHFFFAOYSA-N
REAXYS Number3701645
DescriptionUnited States Pharmacopeia (USP) Reference Standard
MP250-252 °C (dec.) (lit.)
Size50MG
1

A Phase 1-2 Study of Imexon Plus Dacarbazine in Patients With Unresectable Metastatic Melanoma

Jeffrey S Weber, Wolfram E Samlowski, Rene Gonzalez, Antoni Ribas, Joe Stephenson, Steven O'Day, Takami Sato, Robert Dorr, Kathryn Grenier, Evan Hersh

Cancer. 2010 Aug 1;116(15):3683-91.

PMID: 20564083

1

Changes of Immunological Patterns of Human Cancer Cells Treated in Vitro With a Triazene Compound

S D'Atri, P Ballerini, M P Fuggetta, A Faggioni, A Piazza, A Giuliani

Immunopharmacol Immunotoxicol. 1989;11(1):101-18.

PMID: 2547862

1

In Vitro Antitumor Activity of 3'-desamino-3'(2-methoxy-4-morpholinyl) Doxorubicin on Human Melanoma Cells Sensitive or Resistant to Triazene Compounds

E Alvino, S Gilberti, D Cantagallo, R Massoud, A Gatteschi, L Tentori, E Bonmassar, S D'Atri

Cancer Chemother Pharmacol. 1997;40(2):180-4.

PMID: 9182841

1

Oblimersen in the Treatment of Metastatic Melanoma

Ahmad A Tarhini, John M Kirkwood

Future Oncol. 2007 Jun;3(3):263-71.

PMID: 17547520

1

Tumor Immunotherapy: Drug-Induced Neoantigens (Xenogenization) and Immune Checkpoint Inhibitors

Ornella Franzese, Francesco Torino, Maria Pia Fuggetta, Angelo Aquino, Mario Roselli, Enzo Bonmassar, Anna Giuliani, Stefania D'Atri

Oncotarget. 2017 Jun 20;8(25):41641-41669.

PMID: 28404974

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode